Fusion Antibodies (FAB) Share Price, News & Analysis

Company Overview

Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. It serves pharmaceutical, biotech, and diagnostic companies. The company has a collaboration partnership with Celonic AG. The company was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.

Key Stats

• Today's Range: 4.08 to 4.36
• 50-Day Range: 3 to 4.90
• 52-Week Range: 2.80 to 9.50
• Volume: 322,002 shs
• Average Volume: 1.12 million shs
• Market Capitalization: £4.01 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

FAB Stock Analysis - Frequently Asked Questions

How have FAB shares performed this year?

Fusion Antibodies' stock was trading at GBX 4.25 at the beginning of the year. Since then, FAB stock has decreased by 1.2% and is now trading at GBX 4.20.
View the best growth stocks for 2024 here.

How do I buy shares of Fusion Antibodies?

Shares of FAB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Fusion Antibodies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Fusion Antibodies investors own include 4D pharma (DDDD), Omega Diagnostics Group (ODX), Tullow Oil (TLW), Active Energy Group (AEG), B&M European Value Retail (BME), BP (BP) and Coats Group (COA).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: LON:FAB
• CUSIP: N/A
• CIK: N/A
• Web: fusionantibodies.com
• Phone: +44-28-90432800
• Fax: N/A
• Employees: 48
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.04)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £-2,190,000.00
• Net Margins: -195.95%
• Pretax Margin: N/A
• Return on Equity: -152.68%
• Return on Assets: -63.78%

Debt

• Debt-to-Equity Ratio: 2.40
• Current Ratio: 3.87
• Quick Ratio: 2.36

Sales & Book Value

• Annual Sales: £1.14 million
• Price / Sales: 3.51
• Cash Flow: GBX 0.47 per share
• Price / Cash Flow: 9.02
• Book Value: GBX 2 per share
• Price / Book: 2.10

Miscellaneous

• Outstanding Shares: 95,370,000
• Free Float: N/A
• Market Cap: £4.01 million
• Optionable: Not Optionable
• Beta: 0.49